CCA
BHC icon

Catalyst Capital Advisors’s Bausch Health BHC Stock Holding History

Catalyst Capital Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5
Closed -$10K – 557
2015
Q3 		$10K Buy
+5
New +$1.17K ﹤0.01% 473

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Catalyst Capital Advisors's BHC Position: Q1 2016 in Review

Catalyst Capital Advisors sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 62,825 shares — an estimated $4.65M sold.

Catalyst Capital Advisors first reported a position in BHC in Q3 2013 and held it in 10 quarters. The position peaked at $21.2M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • Catalyst Capital Advisors reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • Catalyst Capital Advisors sold 62,825 Bausch Health shares in Q1 2016, an estimated $4.65M.
  • Catalyst Capital Advisors first reported a position in Bausch Health in Q3 2013 and held it in 10 quarters.
  • Catalyst Capital Advisors's Bausch Health position peaked at $21.2M in Q2 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Catalyst Capital Advisors's 13F filing for Q1 2016, filed 11 May 2016.